Polycythemia
Polycythemia is characterized by red blood cell count, hemoglobin, hematocrit and total blood volume significantly exceeding normal levels. In childhood, hemoglobin exceeds 180g/L (16g/dl), hematocrit is greater than 55% and the absolute value of red blood cell volume per kilogram of body weight exceeds 35ml. Relative erythrocytosis caused by blood concentration due to acute dehydration or burns can be excluded, and the disease can be diagnosed. This disease can be divided into two categories: primary and secondary. Primary is true polycythemia; secondary is mainly caused by tissue hypoxia.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Adults -
Related symptoms:
Dizziness fatigue forgetfulness itchy skin double vision -
Concurrent disease:
Relative erythrocytosis Secondary erythrocytosis Hereditary xerocytosis Stomatocytosis Hereditary elliptocytosis
Related Drugs
Xinnaoxin Tablets
Manufacturer:
Jingzhongshan Traditional Chinese Medicine (Tangshan) Co., Ltd.
Xinnaoxin Tablets
Manufacturer:
Chengdu Huayu Pharmaceutical Co., Ltd.
Xinnaoxin Tablets
Manufacturer:
Jiangxi Jinshikang Pharmaceutical Co., Ltd.
Xinnaoxin Tablets
Manufacturer:
Guizhou Yibai Pharmaceutical Co., Ltd.
Xinnaoxin Tablets
Manufacturer:
Zhejiang Kangde Pharmaceutical Group Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Yaopharma Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Yaopharma Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Shanxi Guorun Pharmaceutical Co., Ltd.
Related Ingredients